The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U... Show more
SCHD seeks investment results that correspond to the total return of the Dow Jones U.S. Dividend 100 Index, a benchmark constructed to favor companies with a record of consistent dividend payments, strong balance sheets, and robust free cash flow (FCF, the cash a business generates after capital spending). The fund is a rules-based, passively managed product rather than an actively managed or thematic vehicle, and it weights holdings by market capitalization within that dividend-quality screen.
The portfolio holds approximately 102 securities. Its largest positions include TXN, QCOM, PG, CVX, and KO, alongside Merck, UnitedHealth Group, ConocoPhillips, Verizon Communications, and Amgen. Sector allocation is concentrated in consumer staples (near 20%), healthcare (roughly 19%), technology (about 16%), and energy (roughly 16%), with smaller positions in financial services, industrials, consumer discretionary, and communication services. The expense ratio of 0.06% is among the lowest in the dividend-ETF category.
SCHD operates at the intersection of several durable investment themes: income generation, large-cap value, and quality. Its dividend-quality screen emphasizes companies with sustainable payout ratios and strong fundamentals, which has historically positioned the fund as a defensive complement to growth-oriented portfolios. The portfolio's meaningful energy weighting also ties it to the commodity cycle, while its staples and healthcare exposure provides relatively steady demand characteristics.
The broader macroeconomic backdrop remains relevant to this positioning. Elevated interest rates raise the opportunity cost of holding dividend-paying equities relative to fixed income, yet they also reward companies with pricing power and healthy balance sheets. Inflation trends, monetary policy expectations, and corporate earnings durability continue to shape how investors weigh income-producing assets against higher-growth alternatives.
Over the last 30 days, SCHD has advanced approximately 6%, while its trailing three-month performance stands near 7.5%. This movement has been gradual and range-bound rather than sharply trend-driven, consistent with a period of rotation back toward value and dividend-paying segments after a stretch of growth-stock leadership.
The rebound reflects several identifiable drivers. Strength in large-cap technology holdings such as Texas Instruments and Qualcomm has supported returns, while stabilizing energy prices and resilient consumer-staples demand have lent ballast. Healthcare names, a core sleeve of the fund, have contributed steady performance. Because SCHD's holdings are weighted toward mature, cash-generative businesses, the fund tends to lag in aggressive rallies and to hold up relatively better when risk appetite cools—behavior evident in its recent steadier path higher.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. The tool is designed to surface trending securities, breakout candidates, and emerging opportunities more efficiently than manual screening, giving users a structured way to compare potential investments across sectors and styles. For investors evaluating dividend-oriented products such as SCHD or seeking new ideas across the broader market, the AI Screener offers a practical starting point for focused research.
Several structural factors are likely to shape SCHD's trajectory through 2026. Interest-rate policy remains central: falling yields typically improve the relative appeal of dividend strategies, while persistently higher rates can weigh on valuation multiples for income equities. Inflation dynamics and the pace of economic growth will also matter, as they influence both consumer-staples demand and energy prices, two meaningful sleeves of the portfolio.
Earnings cycles among the fund's largest holdings—particularly semiconductor, energy, and pharmaceutical companies—will be an important swing factor. Capital flows into and out of dividend ETFs, competition from higher-yielding fixed income, and regulatory or policy developments affecting healthcare and energy are additional considerations. Investors should monitor sector rotation between growth and value, commodity-price trends, and the durability of corporate free cash flow, all of which are likely to influence the fund's relative performance without determining its long-term quality-focused mandate.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
SCHD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.
The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 29 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 50 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
SCHD moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.
Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 265 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 285 of 363 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows